Citation Impact
Citing Papers
Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney
2009 StandoutNobel
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
2011 Standout
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas
2016
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
2009
Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis
2001
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Interstitial fluid pressure in cervical carcinoma
1998
Nasopharyngeal carcinoma
2005 Standout
Hepatocellular carcinoma
2003 Standout
High-Throughput Tissue Microarray Analysis to Evaluate Genes Uncovered by cDNA Microarray Screening in Renal Cell Carcinoma
1999
Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?
2000
Lymphangiogenesis and cancer metastasis
2002 Standout
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
2001 Standout
A Phase I Study of Hepatic Arterial Infusion Chemotherapy with Zinostatin Stimalamer Alone for Hepatocellular Carcinoma
2003
Thyroid cancer
2016 Standout
Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation
2002
Predictive Value of Serum Thyroglobulin After Surgery for Thyroid Carcinoma
2003
Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer
2002
Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction
2001 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
2001 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
2001 Standout
Drug penetration in solid tumours
2006 Standout
Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial
2005
CDKN2A Mutation Analysis, Protein Expression, and Deletion Mapping of Chromosome 9p in Conventional Clear-Cell Renal Carcinomas
2001
Head and neck cancer
2008 Standout
Cyclins and Cyclin–Dependent Kinases: Comparative Study of Hepatocellular Carcinoma Versus Cirrhosis
2003
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
2003 Standout
Neuroblastoma: biological insights into a clinical enigma
2003 Standout
Hepatocellular carcinoma
2012 Standout
Serum Thyroglobulin Autoantibodies: Prevalence, Influence on Serum Thyroglobulin Measurement, and Prognostic Significance in Patients with Differentiated Thyroid Carcinoma1
1998
Nasopharyngeal carcinoma
2019 Standout
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Soft-Tissue Sarcomas in Adults
2005 Standout
The international system for staging lung cancer
2000
Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling
2000 StandoutNobel
Osteosarcoma
2010 Standout
Renal cell carcinoma‐infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes
2003
Osteosarcoma treatment – Where do we stand? A state of the art review
2013 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Global cancer statistics
2011 Standout
Polymer conjugates as anticancer nanomedicines
2006 Standout
Tailoring distant metastatic imaging for patients with clinically localized undifferentiated nasopharyngeal carcinoma
2004
Testicular germ-cell tumours in a broader perspective
2005 Standout
Application of post‐surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low‐risk papillary thyroid carcinoma
2010
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients
2005
Should hepatomas be treated with hepatic resection or transplantation?
1999
Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma
2006
Nasopharyngeal carcinoma
2015 Standout
Bladder cancer
2016 Standout
Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system
2002
Early Hepatocellular Carcinoma As An Entity With A High Rate of Surgical Cure
1998
Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study
2000
Impact of moderate vs stringent TSH suppression on survival in advanced differentiated thyroid carcinoma
2011
Multi-institutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapy
2006
Interventional treatment of neuroendocrine liver metastases
2008
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas
2001
Relationship between DNA damage, rejoining and cell killing by radiation in mammalian cells
1996
Plasma Epstein–Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma
2014
Actual role of radiofrequency ablation of liver metastases
2007
Treatment of Stage IVA Hepatocellular Carcinoma
2008
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy
2009
Cancer-related inflammation
2008 StandoutNature
Microinvasive germ cell tumour (MGCT) adjacent to testicular germ cell tumours
2004
Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancer
2003
SERIAL SERUM THYROGLOBULIN MEASUREMENTS IN THE MANAGEMENT OF DIFFERENTIATED THYROID CARCINOMA
1987
The Picture Has Changed in the 1980s
1989
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune response
2003
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues
2000
Principles of and Advances in Percutaneous Ablation
2011
Hepatocellular carcinoma
2022 Standout
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Serum Tumor Marker CA 15.3 and Stage are the Two Most Powerful Predictors of Survival in Primary Breast Cancer
2002
The Benefits and Risks of I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer
2009
Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer.
1994
Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis.
1994 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
The Effect of Repeat Transurethral Resection on Recurrence and Progression Rates in Patients With T1 Tumors of the Bladder Who Received Intravesical Mitomycin: A Prospective, Randomized Clinical Trial
2006
Timing and duration of 5-HT3 receptor antagonist therapy for the prophylaxis of radiotherapy-induced nausea and vomiting: a systematic review of randomized and non-randomized studies
2012
Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer
2014
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Benefit of operative mortality reduction on colorectal cancer survival
2002
Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma.
1996
Cytoplasmic Sequestration of Wild-Type p53 Protein Impairs the G1 Checkpoint after DNA Damage
1996
The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy
2000
Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan.
1995
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
2001 Standout
Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients
1985
Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis
2004
Current status and performance goals for serum thyroglobulin assays
1996
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
DNA Double-Strand Breaks
2002 StandoutNobel
Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma
2000
Long-Term Cardiovascular Mortality in Patients With Differentiated Thyroid Carcinoma: An Observational Study
2013
DNA damage and repair following treatment with ionizing radiation
1990
An audit of management of differentiated thyroid cancer in specialist and non‐specialist clinic settings
2001
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
Thyroid carcinoma
2003 Standout
Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction
2009
Works of A.M. Cassoni being referenced
A new technique of laparoscopic ovariopexy before irradiation
2003
Radiotherapy and conservative surgery in the management of musculo-aponeurotic fibromatosis
1988
A pilot study to evaluate the cost-effectiveness of ondansetron and granisetron in fractionated total body irradiation
1996
The Role of Radiotherapy in Oseosarcoma
2009
Differences in the level of DNA double-strand breaks in human tumour cell lines following low dose-rate irradiation
1992
The Relationship of DNA Double-strand Break Induction to Radiosensitivity in Human Tumour Cell Lines
1990
Radiofrequency ablation of neuroendocrine liver metastases—the Middlesex experience
2005
Radiosensitive Human Tumour Cell Lines May Not Be Recovery Deficient
1988
Tumour volume changes following pre-operative radiotherapy in borderline resectable limb and trunk soft tissue sarcoma
2014
Management of Thyroid Cancer and Related Nodular Disease
2006
Single Center Experience of a New Intensive Induction Therapy for Ewing’s Family of Tumors: Feasibility, Toxicity, and Stem Cell Mobilization Properties
2003
SERUM THYROGLOBULIN IN THYROID CANCER
1981
TNM classification of malignant tumours
1998